Vir Biotechnology CAO Steven Rice receives $2.2M in 2020
Vir Biotechnology reports 2020 executive compensation
By ExecPay News
Published: April 6, 2021
Vir Biotechnology reported fiscal year 2020 executive compensation information on April 6, 2021.
In 2020, five executives at Vir Biotechnology received on average a compensation package of $1.3M, a 50% decrease compared to previous year.
Average pay of disclosed executives at Vir Biotechnology
Steven Rice, Chief Administrative Officer, received $2.2M in total. 68% of Rice's compensation, or $1.5M, was in option awards. Rice also received $257K in non-equity incentive plan and $442K in salary.
Howard Horn, Chief Financial Officer, received a compensation package of $1.6M, which decreased by 26% compared to previous year. 58% of the compensation package, or $960K, was in option awards.
Herbert Skip Virgin, Chief Scientific Officer, earned $1.1M in 2020, a 44% decrease compared to previous year.
George Scangos, Chief Executive Officer, received $995K in 2020, which decreases by 75% compared to 2019.
Michael Kamarck, Chief Technology Officer, earned $804K in 2020.
Related executives
You may also like
Source: SEC filing on April 6, 2021.